Publication: Synthesis And Characterisation Of New Fluorescent Pyrazoline- Piperazinyl Linked Paclitaxel As Prodrugs: Photodynamic Therapy And Anticancer Activity Against Mcf-7 And Mcf-10a Cell Lines
Loading...
Date
2025-05
Authors
Luhaibi, Maadh Jumaah Owaid
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This study involves the synthesis of new pendarflour compounds with combination of photodynamic therapy (pdt) and chemotherapy activity against mcf-7 (cancer cells) and mcf-10a (normal cells) which is an effective strategy to treat cancers. A unique photosensitizer (1-17)a (ps)-conjugated paclitaxel (ptx) (1-15)c prodrug has been developed, in which a ps is excited by near-infrared wavelength light to specifically release ptx while generating singlet oxygen (so) to kill cancer cells. The mechanism involves the use of singlet oxygen to cleave aminoacrylate-type linkers in the prodrug. This generates reactive oxygen species (ros) that induce oxidative damage and cell death. Mcf-7 cell death was triggered by ros surpassing the cell’s redox capacity, leading to apoptosis, confirmed by caspase glo-3/7 assays. A paclitaxel (ptx)-based photosensitive conjugate was developed, where light exposure releases intact ptx, combining chemotherapy with immediate pdt action. Pyrazoline (ps) (1-17)a, a key component of the conjugate, was found to be non-toxic and effective in pdt. Uv/vis absorption and fluorescence emission characteristics were evaluated, revealing the stability and reactivity of the photosensitizer. In vitro studies demonstrated that py-l-ptx induced cell death in the presence of light without affecting cells in the dark.
Description
Keywords
Synthesis Characterisation Fluorescent Pyrazoline- Piperazinyl Linked